Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Azalide macrolide; protein translation inhibito...
Electrophile used in 2’-hydroxyl acylation of...
Monoterpene found in various plant sources.
BRG1/BRM ATPase inhibitor
TLR4 inhibitor.
Enalapril metabolite; ACE inhibitor.
Polyether pyrrole, divalent cation ionophore.
Synthetic peptide, CDPK, PKC, CaMKII substrate....
Methylated derivative of n-octyl-caffeate.
Glucosinolate found in cruciferous vegetables.<...
Bisphosphonate; FPPS inhibitor.
Nucleoside (guanosine) analog; DNA chain termin...
NS3/4A serine protease inhibitor.
NSAID; COX-1/2 and lactate dehydrogenase inhibi...
PDK1 and Akt inhibitor.
PP2A inhibitor.
Cholesterol ester transfer protein inhibitor.
Xanthine alkaloid found in coffee, tea, and oth...
Endogenous peptide hormone, involved in feeding...
NSAID; COX-2 inhibitor.